Agenda

Day 1 Sep 20, 2018

7:00 AM — 8:00 AM

Networking Breakfast

7:00 AM — 5:30 PM

Registration

8:00 AM — 8:15 AM

Welcoming Remarks

8:15 AM — 9:15 AM

Session 1: Current Payer Perspective on the Value of Study Endpoints

9:15 AM — 10:45 AM

Session 2: How Does “Patient Centricity” and Endpoint Evaluation Align or Differ?

10:45 AM — 11:15 AM

Refreshment Break

11:15 AM — 12:15 PM

Session 3: When Does a Patient Feel Well and How is this Measured

12:15 PM — 1:15 PM

Networking Luncheon and C-Path PRO Consortium Update

1:15 PM — 2:00 PM

Session 4: Regulatory Update

2:00 PM — 3:30 PM

Session 5: Endpoint Evolution During Drug Development – Exit Interviews to Develop Qualitative Evidence for PRO Assessments and Endpoints

3:30 PM — 4:00 PM

Refreshment Break

4:00 PM — 5:30 PM

Session 6: Endpoint Evolution During Drug Development – Time to Deterioration Endpoint Case Study

5:30 PM — 6:30 PM

Networking Reception

Day 2 Sep 21, 2018

7:00 AM — 8:00 AM

Networking Breakfast

7:00 AM — 12:00 PM

Registration

8:00 AM — 8:05 AM

Welcoming Remarks

8:05 AM — 9:00 AM

Session 7: DIA Study Endpoints Community Workstream Update

9:00 AM — 10:00 AM

Session 8: The Emerging Role of Novel Devices in Collecting Real-Time Data

10:00 AM — 10:15 AM

Refreshment Break

10:15 AM — 11:30 AM

Session 9: Selecting COA Endpoints and Analyzing COA Data in Rare Disease - Dealing with Small Sample Sizes and Heterogeneity

11:30 AM — 12:30 PM

Keynote Closing Address

12:30 PM — 12:45 PM

Closing Remarks

Have an account?

Advancing the Science of Study Endpoints

Agenda

Be informed and stay engaged.